CA2806519C - Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production - Google Patents

Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production Download PDF

Info

Publication number
CA2806519C
CA2806519C CA2806519A CA2806519A CA2806519C CA 2806519 C CA2806519 C CA 2806519C CA 2806519 A CA2806519 A CA 2806519A CA 2806519 A CA2806519 A CA 2806519A CA 2806519 C CA2806519 C CA 2806519C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
composition according
modified
mixture
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2806519A
Other languages
English (en)
Other versions
CA2806519A1 (fr
Inventor
Carla Labruzzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sofar SpA
Original Assignee
Sofar SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofar SpA filed Critical Sofar SpA
Publication of CA2806519A1 publication Critical patent/CA2806519A1/fr
Application granted granted Critical
Publication of CA2806519C publication Critical patent/CA2806519C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des compositions pharmaceutiques à base de dipropionate de béclométhasone enfermées dans des microsphères gastro-résistantes à libération modifiée et leur utilisation par voie orale dans le cadre du traitement de pathologies inflammatoires du tractus intestinal. Lesdites microsphères contenant lesdites compositions comprennent : a) un cur constitué d'une microsphère d'un matériau inerte ; b) un premier enrobage intermédiaire comprenant du dipropionate de béclométhasone et au moins un excipient physiologiquement acceptable ; et c) un second enrobage gastro-résistant à libération modifiée. La présente invention concerne également un procédé de production desdites compositions.
CA2806519A 2010-08-06 2011-08-02 Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production Active CA2806519C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A001512A IT1405012B1 (it) 2010-08-06 2010-08-06 Composizioni di beclometasone dipropionato in microsfere gastroresistenti a rilascio modificato e processo per il loro ottenimento
ITMI2010A001512 2010-08-06
PCT/IB2011/053430 WO2012017385A2 (fr) 2010-08-06 2011-08-02 Compositions à base de dipropionate de béclométhasone enfermées dans des microsphères gastro-résistantes à libération modifiée et leur procédé de production

Publications (2)

Publication Number Publication Date
CA2806519A1 CA2806519A1 (fr) 2012-02-09
CA2806519C true CA2806519C (fr) 2019-03-26

Family

ID=43707817

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2806519A Active CA2806519C (fr) 2010-08-06 2011-08-02 Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production

Country Status (10)

Country Link
US (1) US10028917B2 (fr)
EP (2) EP2600852A2 (fr)
CA (1) CA2806519C (fr)
CY (1) CY1120931T1 (fr)
DK (1) DK3009130T3 (fr)
ES (1) ES2701264T3 (fr)
HK (1) HK1223570A1 (fr)
IT (1) IT1405012B1 (fr)
PT (1) PT3009130T (fr)
WO (1) WO2012017385A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (fr) * 1980-03-20 1981-10-01 Ferring Farma Lab Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
JP3469926B2 (ja) * 1993-11-04 2003-11-25 太田製薬株式会社 大腸内放出型医薬製剤用粒状物
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
AU710109B2 (en) * 1996-01-16 1999-09-16 Ap Pharma, Inc. Topical delivery of drugs to the lower gastrointestinal tract
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE60237363D1 (de) * 2001-03-15 2010-09-30 Soligenix Inc Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
US8238554B2 (en) 2004-07-22 2012-08-07 Sanyo Electric Co., Ltd. Method for transmission/reception of contents usage right information in encrypted form, and device thereof
US9149439B2 (en) 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
US20080081070A1 (en) * 2006-09-15 2008-04-03 Auriga Laboratories, Inc. Pharmaceutical formulation with enhanced solubility for the delivery of corticosteroids

Also Published As

Publication number Publication date
PT3009130T (pt) 2018-12-14
EP3009130A1 (fr) 2016-04-20
US10028917B2 (en) 2018-07-24
ES2701264T3 (es) 2019-02-21
EP3009130B1 (fr) 2018-10-10
HK1223570A1 (zh) 2017-08-04
ITMI20101512A1 (it) 2012-02-07
CY1120931T1 (el) 2019-12-11
IT1405012B1 (it) 2013-12-16
CA2806519A1 (fr) 2012-02-09
WO2012017385A3 (fr) 2012-04-19
WO2012017385A2 (fr) 2012-02-09
US20130142880A1 (en) 2013-06-06
EP2600852A2 (fr) 2013-06-12
DK3009130T3 (en) 2018-12-17

Similar Documents

Publication Publication Date Title
JP5383183B2 (ja) ロフルミラストを含有する矯味された剤形
ES2452265T3 (es) Composiciones para la administración oral de corticosteroides
WO2014128233A1 (fr) Formulations de stéroïdes administrées par voie orale destinées à être utilisées pour le traitement d'une fibrose intestinale
EP3498264B1 (fr) Préparation pharmaceutique pour administration orale à vitesse de dissolution contrôlée, la préparation comprenant des pastilles à libération prolongée contenant du chlorhydrate de tamsulosine
CN103006607B (zh) 一种兰索拉唑肠溶片及其制备方法
JP5479909B2 (ja) 新規製剤
KR20070115918A (ko) 멀티플 유닛형 경구 서방성 제제 및 그 제조방법
JP5813391B2 (ja) 粒子製剤の製造方法
JP2002526437A (ja) アジテーション非依存性薬学的マルチプル−ユニット持効性製剤およびその製法
KR20150123248A (ko) 유기 화합물의 제제
CN102552256A (zh) 一种艾普拉唑肠溶胶囊及其制备方法
WO2008010524A1 (fr) Procédé servant à produire des granules élémentaires sphériques contenant un médicament aisément soluble dans l'eau
CN112315934B (zh) 白头翁皂苷b4肠溶片的制备工艺
CA2806519C (fr) Compositions a base de dipropionate de beclomethasone enfermees dans des microspheres gastro-resistantes a liberation modifiee et leur procede de production
CN106511291A (zh) 一种盐酸阿考替胺缓释片剂及其制备方法
EP3981469A1 (fr) Agent thérapeutique contre la goutte ou l'hyperuricémie
EP2461802B2 (fr) Compositions granulaires à libération contrôlée contenant de la mésalazine et procédé de fabrication associé
US20220273619A1 (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolylglycyl-l-tyrosinate and methods for preparing the same
JP2007332102A (ja) 腸溶性顆粒剤及びその製造方法
JP3122478B2 (ja) 下部消化管放出型経口製剤
CN112494461A (zh) 一种美沙拉嗪肠溶缓释药物组合物及制备方法
CN102552214A (zh) 一种艾普拉唑肠溶胶囊及其制备方法
EP1100481B1 (fr) Formulations pharmaceutiques servant a traiter la maladie intestinale inflammatoire
JP2022535748A (ja) ピリミジニルアミノピラゾール化合物の調節放出製剤および処置方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160524